Showing results (141-150 of 527) with videos related to
Sort By:
Pageof 53
Therapeutic Advances in Drug Safety|February 25, 2021
Systematic review of immunosuppressant guidelines in the COVID-19 pandemicFenella Barlow-Pay, Thura Win Htut, Mina Khezrian, et al.Therapeutic Advances in Drug Safety|July 31, 2019
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of CongoDidier Nzolo, Andrea Kuemmerle, Yves Lula, et al.Therapeutic Advances in Drug Safety|March 12, 2021
The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmaciesFlorine A Berger, Heleen van der Sijs, Teun van Gelder, et al.Therapeutic Advances in Drug Safety|July 18, 2019
Ceftolozane-tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case seriesXing Tan, Ryan P MoensterTherapeutic Advances in Drug Safety|October 27, 2018
Smoking cessation in pregnancy: a continuing challenge in the United StatesAshley Scherman, Jorge E Tolosa, Cindy McEvoyTherapeutic Advances in Drug Safety|October 17, 2022
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studiesKayeong Shin, Jiwoo Yang, Yeuni Yu, et al.Therapeutic Advances in Drug Safety|January 20, 2025
Drug interactions in patients with alcohol use disorder: results from a real-world study on an addiction-specific wardSebastian Schröder, Christina Massarou, Tabea Pfister, et al.Therapeutic Advances in Drug Safety|January 30, 2025
Is there a risk of esketamine misuse in clinical practice?Carlos Roncero, Milton Merizalde-Torres, Néstor Szerman, et al.Therapeutic Advances in Drug Safety|January 13, 2025
Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting databaseTingting Jiang, Yanping Li, Ni Zhang, et al.Therapeutic Advances in Drug Safety|December 31, 2024
Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, CanadaAlexandre Campeau Calfat, Justin P Turner, Marc Simard, et al.Pageof 53